Global pharmaceutical giant Lupin Limited disclosed that its wholly owned subsidiary, Nanomi B.V., has executed a definitive agreement to acquire VISUfarma B.V., a specialty eye health company backed by GHO Capital Partners...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently held a crucial meeting with the NICDC Logistics Data Services Limited (NLDSL) to launch Logistics e-Marketplace (LeMP) and a new under-development portal search engine regard
FUJIFILM India, a worldwide leader in healthcare technology, has opened an advanced digital radiology X-Ray facility at the Community Health Centre (CHC) in Dholera. This initiative, part of the company's CSR initiative, is intended to address...
Pinkathon, India's largest women's run, and Zydus Lifesciences Ltd., a global healthcare organization driven by innovation, announced the 10th Mumbai Pinkathon, which would take place at MMRDA Grounds, BKC, on December 21, 2025. Zydus has partnered
In a significant move to combat antimicrobial resistance, the Union Health Ministry has banned the import, manufacture, and sale of 34 antimicrobials and their formulations for use in animals
Alembic Pharmaceuticals Limited has announced today that it has obtained final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) pertaining to Paroxetine Extended-Release Tablets USP...
In order to emphasize the vital significance of fair access to contraceptive and reproductive health services across the Asia Pacific area, Organon, a worldwide healthcare organization dedicated to women's health, is working with regional partners
The Competition Commission of South Africa approved Torrent Pharmaceuticals' acquisition of a majority interest in JB Chemicals & Pharmaceuticals from international investment firm KKR on September 22, 2025, giving the company a major boost in its
Novo Holdings, which is the principal stakeholder in Danish developer of diabetes and obesity medications, Novo Nordisk, alongside Canadian pension fund CPPIB, Permira and Chrys Capital, has expressed an appetite to invest into Tata Group's online
Intas Pharmaceuticals launches HETRONIFLY (Serplulimab) in the Indian market, the world's first PD-1 inhibitor to be approved for use in Extensive-Stage Small Cell Lung Cancer (ES-SCLC). This launch is a significant step following its previous...
.jpg)
, CDSCO.jpg)